A transformative scientific paradigm, focused on understanding the vast array of environmental and lifestyle factors influencing human health, is rapidly gaining international momentum, poised to redefine our approach to disease prevention and treatment. This ambitious endeavor, centered around the concept of the human exposome, represents a significant shift in biomedical research, moving beyond a sole focus on genetics to encompass the entirety of non-genetic influences from conception through life. A pivotal moment in this global initiative is anticipated at an upcoming scientific session, moderated by the Financial Times, which will convene leading figures from the Global Exposome Forum in the United States and Europe to update the international research community on the substantial progress made since its inception.
This high-profile discussion, scheduled for February 14th, 2026, from 10:00 AM to 11:00 AM MST in Room West 105 of the Phoenix Convention Center, forms a crucial part of the American Association for the Advancement of Science (AAAS) Annual Meeting. It aims to introduce attendees to what many experts now consider one of the most profound public health opportunities of our era: a comprehensive understanding of the human exposome. Panelists will delve into three critical dimensions: the revolutionary potential inherent in exposomics research, the strategic blueprint for establishing a truly interconnected global network, and the practical strategies necessary to navigate both scientific and policy hurdles that lie ahead.
Professor Thomas Hartung, a distinguished organizer of the panel from the Department of Environmental Health and Engineering at Johns Hopkins University’s Bloomberg School of Public Health, articulated the profound aspirations underpinning this collaborative effort. He conveyed the team’s unwavering resolve, stating, "Our objective here is to generate profound impact, not mere ripples. The dedicated commitment from our Committee Members over the past nine months has been exceptional, and the escalating interest culminating in tangible foundational events and solid commitments is truly inspiring. We have a wealth of encouraging developments forthcoming, and during our panel discussion, we will unveil three specific examples demonstrating significant endorsement from national governments, prominent global scientific organizations, and large membership-driven associations." This session is openly accessible to accredited journalists attending the AAAS Annual Meeting, with a particular invitation extended to researchers and members of the press keen on major public health initiatives and collaborative international endeavors to hear directly from the vanguards of this swiftly evolving domain.
The Human Exposome Project, a brainchild of this burgeoning global movement, is conceived as an undertaking designed to rival, and potentially surpass, the historical significance and scale of the Human Genome Project. While the Human Genome Project undeniably revolutionized our comprehension of hereditary factors, it addressed only a fraction of the complex equation governing disease manifestation. Genetic predispositions are estimated to contribute merely 10-20% to an individual’s lifetime disease risk. In stark contrast, a vast constellation of biological, chemical, and physical environmental exposures is now understood to account for at least 80% of disease susceptibility and progression. These exposures range from air and water quality, diet, lifestyle choices, stress, and infectious agents, to the built environment and socioeconomic conditions.
Despite the undeniable magnitude of this environmental impact on health, coordinated, large-scale initiatives dedicated to systematically studying these multifactorial exposures have been remarkably slow to materialize. However, this historical oversight is now being decisively addressed. Newly established regional chapters and specialized working groups are energetically scaling up exposomics research. This advancement is powered by the synergistic integration of artificial intelligence (AI), cutting-edge sensor technologies capable of real-time monitoring, advanced metabolomics for assessing biological responses, and sophisticated big data analytics to process the immense datasets generated. These multidisciplinary teams are actively forging strategic partnerships across sectors and continents, diligently working to translate nascent scientific breakthroughs into actionable public health policies that promise to benefit entire populations, rather than isolated segments.
This overarching initiative is meticulously structured to harmonize with existing global research efforts while simultaneously possessing the inherent flexibility to expand dynamically in real-time and yield meaningful, measurable returns. Organizers keenly recognize that the successful integration of complex scientific guidance into the policy-making apparatus, particularly concerning emerging and occasionally contentious technologies, is absolutely paramount for long-term success. A foundational principle of the project is a "bottom-up" engagement model, designed to actively involve both ordinary citizens and elected officials, thereby ensuring relevance and public buy-in. Proponents of this comprehensive approach assert that whether the focus is on mitigating childhood conditions like autism and asthma, managing cognitive decline in aging populations, or establishing regulations for ubiquitous environmental contaminants such as microplastics, pesticides, and artificial food colorants, research must pivot towards a holistic understanding of how cumulative exposures interact to influence health outcomes across the lifespan.
A significant stride towards establishing this global network was made on December 1st, 2025, in Pretoria, South Africa. The South African government strategically utilized its Science Forum South Africa and the concurrent World Conference of Science Journalists, both hosted by the Science Diplomacy Capital for Africa (SDCfA), as powerful platforms to propel exposome collaboration across the continent. During this landmark gathering, national and pan-African experts convened to rigorously assess the feasibility and outline the foundational framework for creating a continent-wide exposome network. Senior officials from the Department of Science, Technology and Innovation (DSTI) also received dedicated briefings, underscoring the high-level governmental commitment. South Africa had previously demonstrated its early engagement by participating at the Deputy Director-General level in the inaugural Washington D.C. launch of the Human Exposome Project in May 2025.
An immediate and tangible outcome of the Pretoria meeting was a formal agreement for pan-African experts to directly engage with the various working groups of the Global Exposome Forum and actively participate in thematic meetings held worldwide. A critical early priority identified through these discussions is the imperative to significantly improve the coordination and standardization of health data reporting systems across African nations. A follow-up workshop, marking one year since the initial gathering, is strategically scheduled for early December 2026. In a further demonstration of commitment, the SDCfA has formally expressed its readiness to serve as the founding host institution for the proposed pan-African exposome network, solidifying Africa’s role as a vital pillar in this global scientific endeavor.
Beyond regional expansion, the integration of scientific advice into policy-making forms another crucial component of the Global Exposome Forum’s strategy. Professor Rémi Quirion, President of the International Network for Governmental Science Advice (INGSA), has emerged as an ardent and proactive supporter of exposomics and the rapidly expanding international consortium driving it. INGSA played a pivotal role by organizing a dedicated policy-focused panel during the May 2025 meeting in Washington, D.C. This influential session featured an esteemed roster of speakers, including chief scientists and senior leaders from venerable organizations such as UNESCO, the World Health Organization (WHO), and the African Academy of Sciences, underscoring the intergovernmental and inter-agency interest in this field.
Since that foundational meeting, INGSA has continuously facilitated ongoing, substantive discussions with the Global Exposome Forum, specifically addressing how the ethical dimensions of exposome research—termed ‘exposomethics’—can be effectively and responsibly integrated into the policymaking process. Another high-level session, co-organized by INGSA, is slated for April 29th, 2026, as part of the broader Global Exposome Summit in Sitges, Spain. Furthermore, INGSA has formalized its commitment to collaborate with the Global Exposome Forum, leveraging its extensive 10,000-member network and continental chapters to provide expert advice on strategic engagement with science advisory systems across the globe, thereby embedding exposomics within national and international policy frameworks.
In another significant partnership, on December 8th, 2025, the Global Exposome Forum formally launched a collaboration with the Human Cell Atlas (HCA) and UNESCO. This strategic alliance encompasses a series of focused virtual town halls designed to explore the convergence of single-cell analysis, genomics, exposomics, and science policy. UNESCO, which had senior-level representation at the May 2025 Washington D.C. meeting, is poised to host a critical follow-up session in Paris on March 3rd, 2026, to be attended at the Assistant Director-General level. This upcoming meeting is specifically intended to finalize preparations for the signing of a comprehensive Memorandum of Understanding between UNESCO and the Global Exposome Forum, solidifying a long-term collaborative framework.
The momentum behind the exposome initiative continues to build steadily across the world. Beyond Africa, regional chapters are actively being established in key geographical areas, including Latin America and the Caribbean, as well as Southeast Asia, demonstrating a truly global reach. In Europe, the European Exposome Forum is diligently organizing the flagship Global Exposome Summit, scheduled to take place in Sitges, Spain, from April 27th to 29th, 2026. Early registration figures have already surpassed initial expectations, signaling widespread interest and enthusiasm. This summit is rapidly shaping up to be a convergence point for leading voices across diverse fields, including health science, artificial intelligence, supercomputing, and forward-looking policymaking, promising a rich exchange of ideas and collaborative opportunities.
At the operational core of the Global Exposome Forum’s strategy lies the establishment of specialized, member-driven working groups. These teams are specifically tasked with defining and collaboratively addressing some of the most pressing scientific and policy questions confronting the nascent field of exposomics. Comprising participants drawn from diverse sectors—industry, government, academia, and civil society—these groups collaborate seamlessly through a dedicated digital platform. This sophisticated platform is meticulously designed to facilitate efficient messaging, secure document sharing, and robust coordinated international work, ensuring that geographical boundaries do not impede scientific progress. These working groups are not merely administrative units; they represent a fundamental structural element of the Global Exposome Forum, embodying its grassroots, member-led philosophy while simultaneously enabling large-scale coordination and interdisciplinary collaboration across national borders and professional sectors.
Collectively, these multifaceted developments—from regional network expansion and strategic international partnerships to policy integration and advanced digital collaboration—signal a definitive shift from the foundational planning stages to robust, real-world implementation. Through meticulously coordinated public and private sector partnerships, sustained international cooperation, and the establishment of shared research infrastructure, the Global Exposome Forum is actively propelling exposomics from an emerging, theoretical concept into a tangible, transformative force. This concerted global effort promises to revolutionize public health strategies and reshape the landscape of modern medicine, moving towards a future where disease prevention is not just reactive but proactively informed by a holistic understanding of every individual’s unique environmental and lifestyle fingerprint.
About the Author
